What is American Vanguard's latest dividend and current dividend yield?

What were the key takeaways from American Vanguard’s earnings call?

What is the market's earnings forecast for American Vanguard next quarter?

What does American Vanguard do and what are its main business segments?

What guidance did American Vanguard's management provide for the next earnings period?

Did American Vanguard beat or miss consensus estimates last quarter?

What is the revenue and EPS growth rate for American Vanguard year over year?

What factors drove the changes in American Vanguard's revenue and profit?

- **2025 Progress**: $39.2M EBITDA, $4M annual savings from LA closure, 1 new product launched
- **2026 Outlook**: EBITDA $44-48M, sales $530-550M, targeting 15% margin by 2031
- **Growth Drivers**: 5 new products in 2026, $100M+ pipeline revenue
- **Efficiency**: Inventory turns 2.25x, $0.5M annual HQ savings
- **Cash Flow**: Positive 2026 with $5-10M CapEx

**【CEO Opening Remarks】**
- 2025 was challenging but marked by progress: $39.2M adjusted EBITDA (slightly above prior year), cost-cutting ($4M annual savings from LA facility closure), and new product pipeline (1 launched in 2026, 5 planned for 2026, 25+ by 2031). 
- Key initiatives: 
  - Digital transformation and operational efficiency (inventory turns target 2.25x, reducing working capital)
  - Commercial restructuring (new Chief Commercial Officer to drive factory utilization)
  - Debt refinancing with Centerbridge and BMO for financial flexibility
- 2026 outlook: Adjusted EBITDA $44-48M, sales $530-550M, driven by new products and cost containment.

**【CFO Financial Commentary】**
- 2025 Results: 
  - Sales $515M (-6% YoY), underpinned by specialty sales growth (+10%)
  - Gross margin improved to 29%, OpEx as % of sales down to 27%
  - $39.2M adjusted EBITDA (flat YoY), constrained by $50M lower prepay collections
- 2026 Focus: 
  - Reduce net working capital through modern supply chain software
  - CapEx $5-10M for operational efficiency
  - Remediated all material weaknesses in 2025 audit

**【Q&A Highlights】**
- **Q4 Weakness**: Driven by lower U.S. metam sales (-potato acres) and international channel inventory (Mexico/Mexico, Australia drought)
- **Long-Term Targets**: 15% EBITDA margin achievable via 4-6% sales growth + cost efficiency
- **Cash Flow**: 2026 free cash flow positive (adjusted EBITDA - interest - CapEx)
- **Product Pipeline**: $100M+ new product revenue by 2031 (fungicides, herbicides, insecticides)
- **Asset Sales**: No proceeds from LA facility closure; focus on operational savings ($4M annual)


American Vanguard Corporation (AVD) Q4 2025 Earnings Call Transcript

- **Record EBITDA Growth**: 350% YoY jump to $8.2M, driven by $6M expense cuts and operational efficiency.
- **Gross Margin Expansion**: 300bps improvement to 29%, fueled by lower COGS and manufacturing savings.
- **Specialty Recovery**: $2M product liability claims resolved, Q4 sales rebound expected.
- **$100M Pipeline**: New product pipeline to drive 2027+ growth, positioning for industry consolidation.
- **Debt Reduction Focus**: Target to cut net debt/EBITDA ratio below 3x via free cash flow ($20M+ annualized).

**【CEO Opening Remarks】**
- Adjusted EBITDA increased 350% YoY to $8.2 million, driven by cost reductions and operational efficiency improvements.
- Gross profit margin improved by 300 basis points YoY, with $6 million reduction in operating expenses.
- Specialty business renamed to reflect innovation, with $100 million pipeline of new products over the medium term.
- 2025 full-year EBITDA target maintained at $40-$44 million despite challenging agricultural market.

**【CFO Financial Commentary】**
- Q3 2025 revenue $119 million (flat YoY, but +1% excluding nonrecurring item).
- U.S. crop business strong (+50% herbicides, +5% granular insecticides), offset by weakness in Specialty (product liability claims) and International (weather impacts).
- Gross margin expanded to 29% (vs. 15% YoY), driven by lower inventory costs and manufacturing efficiencies.
- Operating expenses down 11% QoQ ($5M reduction), with R&D and transformation costs cut significantly.
- Product liability claims expense recorded at $2M, expected to be reimbursed by third parties.
- Inventory reduced by $47M YoY, net trade working capital down $24M.

**【Q&A Highlights】**
- **U.S. Crop Business**: Strong Q3 performance with normalized demand, corn acreage growth expected to drive 2026 volumes.
- **Specialty Business**: Product liability claims resolved, customer trust restored, Q4 recovery anticipated.
- **Free Cash Flow**: Expect $20M+ for 2025 (EBITDA $40-44M - CapEx $5-6M - interest $20M).
- **Leverage Reduction**: Target to reduce net debt/EBITDA ratio below 3x through debt refinancing.
- **Market Trends**: Channel inventories at multi-year lows, pricing stabilization, cautious optimism on China trade resolution.
- **Acquisition Pipeline**: Positioning to capitalize on industry consolidation (e.g., Corteva split) with $100M+ new product pipeline maturing 2027-2029.

American Vanguard Corporation (AVD) Q3 2025 Earnings Call Transcript

- **Revenue Resilience**: $129M Q2 sales (flat YoY) with 1% growth in U.S. crop/non-crop segments.
- **Profit Leap**: EBITDA nearly doubles to $11M, gross margin expands to 31% (vs. 29% YoY).
- **Cost Control**: $5M OpEx savings, debt down $22M YoY to $189M.
- **Green Growth**: Segment ahead of company, Central/South America sales set to surge in H2.
- **Factory Efficiency**: Aiming for 2x inventory turns (1.475 currently), with strategic production alignment.
- **Debt Management**: Credit facility extension discussions underway with BMO.

**【CEO Summary Section】**
- **Revenue Growth**: Q2 2025 net sales of $129 million, up 1% YoY, driven by U.S. crop and non-crop segments. Adjusted EBITDA nearly doubled to $11 million (vs. $6 million in Q2 2024).
- **Cost Efficiency**: Operating expenses as a % of sales improved to 27% (from 31% YoY), with $5 million in OpEx savings (SG&A down $2M, R&D down $3M).
- **Gross Margin Expansion**: 31% gross profit margin (vs. 29% YoY), attributed to improved SIOP process, manufacturing efficiency, and new procurement team.
- **Green Solutions Momentum**: Segment growing ahead of company, with Central/South American sales expected to strengthen in H2.
- **Inventory Management**: Inventory up 7% YTD (vs. 12% YoY and 29% in 2023), down $53M YoY, freeing up cash flow.
- **Debt Reduction**: Debt outstanding $189M (vs. $211M YoY), driven by improved cash cycle.
- **Long-Term Goals**: Target 15% EBITDA margin, 2x inventory turns (currently 1.475), and $40-44M 2025 EBITDA.

**【CFO Financial Commentary】**
- **Revenue Performance**: $129M revenue (flat YoY), with strength in corn acreage and granular soil insecticides offsetting cotton weakness.
- **Gross Margin Drivers**: 31% margin (vs. 29% YoY) from better demand planning, production scheduling, and procurement.
- **Cash Flow Focus**: $5-6M 2025 CapEx, targeting $40-44M EBITDA to generate free cash flow for debt reduction.
- **Credit Facility Update**: Discussions with lenders to extend $189M facility (due Q3 2026), leveraging multi-decade relationship with BMO.

**【Q&A Highlights】**
- **Credit Facility Extension**: CFO Johnson confirms "productive conversations" with lenders, aiming to secure amendment within timeline.
- **Procurement Strategy**: CEO Kaye credits new procurement team and SIOP process for 31% gross margin, noting procurement professionals "pay for themselves almost instantaneously."
- **Factory Utilization**: Underutilized plants seeing improved efficiency, with initiatives to align production across facilities and explore toll manufacturing.
- **Inventory Targets**: Aiming for 2x inventory turns (currently 1.475), with progress expected by 2027.
- **SIMPAS Technology**: Ongoing discussions to monetize unique agricultural technology, though no updates yet.

American Vanguard (AVD)-31 Jul 25-2025 Q2 Earnings call transcript

- **Revenue and EBITDA Misses**: Q1 2025 net sales down 14% YoY to $116 million; EBITDA slashed to $3 million (-81% YoY) due to destocking and product cancellations.
- **Cost Efficiency Gains**: Operating expenses reduced by $5 million YoY; net working capital improved by $86 million YoY.
- **Market Recovery Signals**: U.S. channel inventories at historic lows; corn acreage at 9-year high, driving soil fumigant demand.
- **Revised Outlook**: Full-year 2025 EBITDA guidance lowered to $40-44 million; free cash flow to focus on debt reduction.
- **Competitive Risks**: Short-term pricing pressure in Q1, but U.S. production advantage for key products like Folex provides long-term resilience.

**【CEO Summary Section】**
- **Q1 2025 Financials**: Net sales of $116 million (-14% YoY), adjusted EBITDA of $3 million (-81% YoY) due to destocking, product cancellations, and market weakness.
- **Cost Management**: Operating expenses down $5 million YoY; net trade working capital reduced by $86 million YoY.
- **Market Trends**: U.S. channel inventories at historic lows; corn acreage at highest since 2013-14, peanut acreage growth driving Thimet sales (+17%).
- **Revised Guidance**: Full-year 2025 EBITDA target lowered to $40-44 million (from $45-52 million); revenue $535-545 million.
- **Strategic Focus**: Cost containment, working capital optimization, and product portfolio investments.

**【CFO Financial Commentary】**
- **Revenue Decline**: $116 million (-14% YoY) due to destocking, Dacthal cancellation, Mexican agave weakness, and Australian drought.
- **Gross Margin**: 26% (vs. 31% YoY) due to pricing pressure and lower volume.
- **Working Capital**: Inventory up 3% QoQ but down 20% YoY; debt reduced by $20 million YoY.
- **Debt Management**: Exploring long-term financing amid higher interest rates; free cash flow expected to be allocated to debt reduction.
- **Customer Programs**: Increased incentives to maintain market share, impacting gross profit.

**【Q&A Key Highlights】**
- **Dacthal Impact**: Removed $6 million in revenue and 3.5% gross margin YoY.
- **Seasonality**: Second half of year accounts for majority of revenue; Q1 2025 represented ~22% of full-year guidance midpoint.
- **Competitive Pricing**: Short-term discounting in Q1, but U.S.-based production advantage for Folex expected to mitigate long-term generic pressure.
- **Cash Taxes**: ~$4-5 million expected for 2025, primarily international.
- **Corn vs. Soy**: Higher crop protection usage per corn acre; corn acreage growth aligns with soil insecticide sales trends.


American Vanguard (AVD)-6 Jun 25-2025 Q1 Earnings call transcript

- **2024 Performance**: Achieved $42M EBITDA (vs. $40-50M target), $563M Revenue (near $565-580M range). 2025 Outlook: EBITDA $45-52M, Sales $565-585M.
- **Margin Expansion**: 7.5% 2024 EBITDA margin → Targeting double-digit over 3-4 years via cost-cutting and process simplification.
- **Debt Reduction**: $22M paid in Q4, 2025 free cash flow to repay debt.
- **Tariff Impact**: < $3M EBITDA impact, but farmer caution delays restocking.
- **2025 Growth Drivers**: ERP implementation, inventory turns to 2.0, and modern management techniques.
- **One-Time Costs**: $118M in 2024, 2025 transformation costs drop to $8-10M.

**【CEO Opening Remarks】**
- 2024 Adjusted EBITDA: $42 million (within $40-50 million target), Adjusted Revenue: $563 million (slightly below $565-580 million range). 2025 Target: EBITDA $45-52 million, Sales $565-585 million.
- 2024 EBITDA Margin: 7.5%, aiming for double-digit margin growth over 3-4 years via simplification and modern management techniques.
- 2024 One-Time Charges: $118 million (asset impairments $76M, transformation costs $42M) to reposition for long-term growth.
- 2025 Free Cash Flow: ~$10M for debt repayment, CapEx $10 million.
- Farm Economy: Gradual improvement, channel buying 'just-in-time' due to high capital costs and tariff uncertainty.

**【CFO Financial Highlights】**
- Q4 2024 Revenue: $169 million (-2% YoY), Adjusted EBITDA: $18 million (-18% YoY).
- Debt Reduction: $22 million in Q4, Inventory: $180 million (incl. $20M write-downs).
- Inventory Turns: 1.67 in 2024, targeting 2.0 by end-2025.
- 2024 Non-Recurring Charges: $118 million (SIMPAS write-down $22.4M, Goodwill $27M, Slow-Moving Inventory $20M).
- 10-K Filing Delay: Due to complexity of write-downs, aiming to file as soon as possible.

**【Q&A Key Takeaways】**
- **Tariff Impact**: < $3M EBITDA impact in 2025, but farmer caution persists due to potential reciprocal tariffs.
- **Inventory Management**: 2024 inventory reduced by $47M, 2025 focus on 2.0 inventory turns via new SIOP model and ERP implementation.
- **Organizational Complexity**: Simplification through ERP, streamlined processes, and new hires (Mike DiPaola, Jared Stanley) to drive efficiency.
- **2025 Margin Cadence**: Lower Q1/Q2, stronger H2 with EBITDA margin improving sequentially.
- **Transformation Costs**: $8-10 million in 2025 (commercial $4-5M, logistics $2-3M, org $2M), down from $118M in 2024.
- **Tariff Situation**: Fluid, but current impact on raw materials negligible. Farmer sentiment cautious but improving.
- **Working Capital**: Focus on inventory reduction, no significant other WC inflows expected in 2025.

Actual										0.02	0.13	0.1	0.26	0.1	0.17	0.18	0.16	0.33	0.23	0.13	0.07	-0.04	-0.01	0.24	0.06	-0.42	-0.92	-3.22	-0.3	-0.03	-0.43	-0.99
Forecast										0.0067	0.11	0.115	0.22	0.01	0.1	0.17	0.24	0.2	0.21	0.075	0.28	0.32	0.12	0.27	0.125	-0.045	-0.095	0.2	-0.07	-0.11	-0.08	0.28
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+198.51%	+18.18%	-13.04%	+18.18%	+900.00%	+70.00%	+5.88%	-33.33%	+65.00%	+9.52%	+73.33%	-75.00%	-112.50%	-108.33%	-11.11%	-52.00%	-833.33%	-868.42%	-1710.00%	-328.57%	+72.73%	-437.50%	-453.57%

Actual	--	--	--	--	--	--	--	--	--	95.96M	104.56M	117.44M	140.75M	116.16M	134.61M	147.30M	158.81M	149.44M	152.12M	159.98M	124.89M	132.79M	149.52M	172.20M	135.14M	128.21M	118.31M	165.65M	115.80M	129.31M	119.31M	150.69M
Forecast	--	--	--	--	--	--	--	--	--	98.23M	116.63M	118.20M	144.55M	110.05M	117.50M	135.00M	153.30M	130.50M	156.80M	158.55M	158.45M	166.00M	151.15M	172.75M	141.90M	133.60M	139.20M	169.00M	127.00M	125.00M	128.00M	163.00M
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-2.31%	-10.36%	-0.64%	-2.63%	+5.55%	+14.56%	+9.11%	+3.59%	+14.51%	-2.99%	+0.90%	-21.18%	-20.01%	-1.08%	-0.32%	-4.76%	-4.04%	-15.01%	-1.98%	-8.82%	+3.45%	-6.79%	-7.55%

AVD

AVD fundamentals

AVD Q4 2025 Earnings

Earnings Call

You can ask Aime

AVD

AVD fundamentals

AVD Q4 2025 Earnings

Earnings Call

AVD Earnings Call Summary for Q4/202510:30 AM on Mar 16, 2026

AVD Earnings Call Summary for Q3/20259:00 AM on Nov 10, 2025

AVD Earnings Call Summary for Q2/20255:00 PM on Jul 31, 2025

AVD Earnings Call Summary for Q1/20259:00 AM on Jun 6, 2025

AVD Earnings Call Summary for Q4/20249:00 AM on Mar 14, 2025

You can ask Aime